Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Completed 71Recruiting 55Terminated 38Active not recruiting 25Unknown 14Withdrawn 9Not yet recruiting 6Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 3Glioma 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenoviridae Infections 2Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neurofibrosarcoma 1Neuroblastoma 1Neoplasms 1Multiple Myeloma 1Metastatic Castration-resistant Prostate Cancer 1Mesothelioma, Malignant 1Melanoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Graft vs Host Disease 1Glioblastoma 1Gastro-enteropancreatic neuroendocrine tumor 1Esophageal Squamous Cell Carcinoma 1Epstein-Barr Virus Infections 1Cytomegalovirus Infections 1Colorectal Neoplasms 1Cholangiocarcinoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Enrolling by invitation × Squamous Cell Carcinoma of Head and Neck × Clear all
NCT06690216 2025-03-30

PD-L1-PET

Shandong Cancer Hospital and Institute

Phase 1/2 Enrolling by invitation
100 enrolled
CNSGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡